Today: 21 May 2026
Zurn Elkay stock jumps nearly 12% after outlook, cash targets catch buyers’ eye
4 February 2026
1 min read

Zurn Elkay stock jumps nearly 12% after outlook, cash targets catch buyers’ eye

New York, February 4, 2026, 15:09 EST — Regular session

Shares of Zurn Elkay Water Solutions Corporation climbed 11.6% to $52.52 in afternoon trading Wednesday, hitting an intraday peak of $52.74. The stock gained $5.46 on the day, with roughly 1.7 million shares changing hands.

This move is significant since investors tend to dump building-products stocks whenever pricing power wavers or demand slows. Zurn Elkay’s update came right in the thick of that selling pressure.

This is also a cash story. Firms that maintain steady margins while generating solid cash flow usually get rewarded quickly once sentiment shifts even a bit toward caution.

Late Tuesday, the Milwaukee-based water-management products maker reported Q4 net sales of $407 million, up from $371 million a year ago, with adjusted earnings hitting 36 cents per share. Adjusted EBITDA climbed to $104 million. CEO Todd Adams highlighted record results for 2025 and a year-end net debt leverage ratio of just 0.4x.

The company projects mid-single digit core sales growth for 2026, with incremental adjusted EBITDA margins near 35% and free cash flow around $335 million. For Q1, it forecasts core sales growth between 7% and 8%, and adjusted EBITDA margins in the 25.5% to 26.0% range. It also noted that its 2025 sustainability report will be released “in the coming weeks.” SEC

Core sales serve as the company’s “organic” benchmark, designed to exclude acquisition and currency impacts. Incremental margin measures the portion of each additional dollar in sales that flows through to profit — a straightforward gauge of operating leverage.

Other plumbing and building-products stocks also climbed, but none matched Zurn’s leap. Fortune Brands Innovations jumped roughly 7%, Watts Water Technologies edged up close to 2%, and Advanced Drainage Systems rose around 3%.

The bid also reveals investor sentiment on the early-2026 outlook. Should cash remain robust, buybacks and balance-sheet flexibility will help carry the load, even if volume growth wavers.

But with the rally underway, there’s little margin for slip-ups. Should commercial construction falter or price gains stall sooner than anticipated, margins could compress rapidly, and cash flow might suffer from typical working-capital fluctuations.

Macro factors continue to weigh on the market, particularly anything that shifts rate expectations. The U.S. Bureau of Labor Statistics announced the delayed January jobs report will drop next Wednesday, while the January CPI release is pushed to next Friday following a three-day government shutdown.

Advanced Drainage Systems will report before the bell on Thursday, February 5, per Kiplinger’s earnings calendar. Investors will be watching for clues on construction-related demand.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Strategy (MSTR) stock slides with bitcoin near $73,000 as filing shows fresh BTC buy and analyst cuts target
Previous Story

Strategy (MSTR) stock slides with bitcoin near $73,000 as filing shows fresh BTC buy and analyst cuts target

Why ESAB stock is jumping today: Eddyfi deal digested, early numbers set the tone
Next Story

Why ESAB stock is jumping today: Eddyfi deal digested, early numbers set the tone

Go toTop